Diabetes author in book festival talk
Author Dr David Cavan will be talking about his bestselling book ‘Reverse Your Diabetes’ at the Bradford Literature Festival this weekend. He will be tackling the myths and ...
Author Dr David Cavan will be talking about his bestselling book ‘Reverse Your Diabetes’ at the Bradford Literature Festival this weekend. He will be tackling the myths and ...
Screening to identify Type 2 diabetes followed by early treatment could result in substantial health benefits, according to new research. Published this week in Diabetes Care, the study, led by ...
Europe will face a major obesity crisis by 2030 sparking fears of a rise in Type 2 diabetes, according to the latest projections by the World Health Organization (WHO). In the UK, one third (33 ...
The author of a book about ‘reversing’ Type 2 diabetes is hosting a live social media chat on Sunday, May 10. Dr David Cavan will be answering questions from 7pm-8pm on the Facebook ...
Tracey Albert, 47, a former sales and marketing manager, is divorced and lives in Medway Kent. She has three children and three grandchildren. She said: “I’d always been a healthy size 10 ...
A new treatment for Type 2 diabetes has been recommended for the NHS by health watchdog NICE. Empagliflozin, also known as Jardiance, has been recommended as a treatment for Type 2 diabetes when ...
Each hour spent watching TV increases the risk of developing Type 2 diabetes by 3.4 per cent, a study has found. Researchers from the University of Pittsburgh looked at the effects of sedentary ...
The prevention of avoidable ill health and promotion of healthier lifestyles should be a priority of the next government, Diabetes UK has said on the back of a report by MPs. GPs should tell ...
The NHS and Public Health in England will today start a major national initiative to prevent illness by unveiling the first ever at-scale National NHS Diabetes Prevention Programme. Simon ...
Health watchdog NICE has issued further draft guidance which recommends empagliflozin, marketed by Boehringer Ingelheim, for treating Type 2 diabetes. In a preliminary appraisal last August, NICE ...